Head, Section of Vascular Surgery Stanley Professor of Surgery, University Mich Medical School
Vascular Surgery
Dr. Thomas W. Wakefield, MD
|
|
Give Review
Dr. Thomas W. Wakefield practices Vascular Surgery. He graduated from University of Toledo College of Medicine. He has 55 awards "America's Top Doctors", "Servier Traveling Research Award", "Coeur D'OR Award for Excellence", "Coeur DOR Award for Excellence", "Distinguished Alumnus Award", "Venous Research Award of the Venous Disease Coalition", "CMS Meaningful Use Stage 1 Certification", "ATVB Distinguished Invited Lecture", "Best Poster", "1st Place Oral Presentation", "Invited speaker, AOA Induction Ceremony", "James K. Larson Award for Outstanding Career Achievement", "Emerick Szilagyi Award", "Servier Traveling Fellowship", "Elected", "Honorary Membership", "Participation in Surgeon General's Conference on VTE", "Participation in ASH/NIH Conference on VTE and Aging", "Distinguished Reviewer", "America's Top Doctors (America's Top Doctors by Specialty)", "Americas Top Doctors (Americas Top Doctors by Specialty)", "One of America's Best Doctors", "One of Americas Best Doctors", "President", "Order of Excellence", "President-Elect", "Distinguished Fellow", "Detroit's "Top Docs"", "Award for Excellence in Vascular Surgical Research", "William J von Liebig Foundation Award for Excellence in Vascular Surgical Research", "Selection into Strathmores Whos Who", "Selection into Strathmore's Who's Who", "Award for best poster", "Frederick A. Coller Surgical Society Conrad Jobst Award", "Beiersdorf-Jobst Research Award", "Jody C. Underleider Award for Animal Welfare", "2000 Beiersdorf-Jobst Research Award", "James W. Crudup Award", "1st Place, Venous Research Award", "Lindenauer Vascular Research and Education Award", "Emerick Szilagyi Michigan Vascular Prize", "Charles C. Guthrie Award for Original Research in Vascular Disease", "Charles C. Guthrie Award", "Finalist, The Jobst Research Fellowship", "Finalist", "Induction into St. John's High School Hall of Fame", "3rd Place, Venous Research Award", "Bronze Beeper Award for Outstanding Teaching", "Conrad Jobst Award", "Conrad Jobst Award for Research in Vascular Surgery", "Phi Kappa Phi Graduate Scholarship", "Governor's Award", "Top State Science Student", "National Winner" and "Fellow (FACS)". Thomas Wakefield is a published doctor. He published 100 publications, including: '1D-(1)H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosis.' He accepts Medicare.
Publications
- 1D-(1)H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous Thrombosis.
- Use of the Clinical, Etiologic, Anatomic, and Pathophysiologic classification and Venous Clinical Severity Score to establish a treatment plan for chronic Venous disor...
- Validation of the Caprini Venous Thromboembolism Risk Assessment Model in Critically Ill Surgical Patients.
- A prospective evaluation of standard versus battery-powered sequential Compression devices in postsurgical patients.
- Inferior vena cava branch variations in C57BL/6 mice have an impact on thrombus size in an IVC ligation (stasis) model.
- The role of galectin-3 and galectin-3-binding protein in venous Thrombosis.
- An aspirin a day to keep the clots away: can aspirin prevent recurrent Thrombosis in extended treatment for venous thromboembolism?
- PAI-1 over-expression decreases experimental post-thrombotic Vein wall fibrosis by a non-vitronectin dependent mechanism.
- Reliability of hospital readmission rates in Vascular surgery.
- Recanalization of the intentionally interrupted inferior vena cava.
- Plasma DNA is Elevated in Patients with Deep Vein Thrombosis.
- Matrix metalloproteinase-9 deletion is associated with decreased mid-term Vein wall fibrosis in experimental stasis DVT.
- Soluble P-selectin for the diagnosis of lower extremity Deep venous thrombosis.
- The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic Vein wall remodeling.
- The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse.
- Circulating and Vein wall P-selectin promote venous thrombogenesis during aging in a rodent model.
- Rosuvastatin reduced Deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.
- The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental Deep vein thrombosis.
- Biomarkers for the diagnosis of Deep vein thrombosis.
- Identifying patients at high risk for Venous thromboembolism requiring treatment after outpatient surgery.
- Inflammation and Thrombosis: new insights.
- Myeloid cell tissue factor does not contribute to Venous thrombogenesis in an electrolytic injury model.
- Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments Deep vein thrombosis.
- The effect of Abdominal wall plication on intra-Abdominal pressure and lower extremity venous flow: A case report.
- Commentary on "Venous Trauma: New Lessons and Old Debates"
- Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis.
- Longevity and outcomes of axillary valve transplantation for severe lower extremity chronic Venous insufficiency.
- Interleukin-6: a potential target for post-thrombotic syndrome.
- von Willebrand factor-mediated platelet adhesion is critical for Deep vein thrombosis in mouse models.
- Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis.
- Postthrombotic Vein wall remodeling: preliminary observations.
- Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis.
- Toll-like receptor 9 signaling is critical for early experimental Deep vein thrombosis resolution.
- The Sixth Pacific Vascular Symposium: the Venous ulcer summit.
- Reducing Venous stasis ulcers by fifty percent in 10 years: the next steps.
- Anticoagulant treatment for superficial venous Thrombosis.
- Extracellular DNA traps promote Thrombosis.
- What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
- Venous thromboembolic events in the rehabilitation setting.
- Proteomics of microparticles after Deep venous thrombosis.
- Do galectins play a role in venous Thrombosis? a review.
- P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous Thrombosis: a meta-analysis.
- Chronic venous insufficiency: current management of varicose Vein disease.
- Vein wall remodeling after Deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
- A validation study of a retrospective Venous thromboembolism risk scoring method.
- Aging is associated with impaired thrombus resolution in a mouse model of stasis induced Thrombosis.
- Microparticle surface protein are associated with experimental venous Thrombosis: a preliminary study.
- Metabolic consequences of Acute limb ischemia and their clinical implications.
- Role of selectins and fibrinolysis in VTE.
- Thromboembolic Diseases.
- In brief. Thromboembolic Disease.
- Venous thromboembolism in cancer patients undergoing major surgery.
- Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III).
- Increasing awareness about Venous disease: The American Venous Forum expands the National Venous Screening Program.
- Vein wall re-endothelialization after Deep vein thrombosis is improved with low-molecular-weight heparin.
- Mechanisms of venous Thrombosis and resolution.
- Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review.
- Mapping the future: organizational, clinical, and research priorities in Venous disease.
- Acute venous disease: venous thrombosis and venous trauma.
- Preface: Acute and chronic venous disease. Current status and future directions.
- CT venography and Compression sonography are diagnostically equivalent: data from PIOPED II.
- Plasmin inhibition increases MMP-9 activity and decreases Vein wall stiffness during venous thrombosis resolution.
- Factors associated with outcome after interventional treatment of symptomatic iliac Vein compression syndrome.
- CT venography for Deep venous thrombosis: continuous images versus reformatted discontinuous images using PIOPED II data.
- Venous thromboembolism and cancer.
- Risk factors and clinical impact of postoperative symptomatic Venous thromboembolism.
- IlioRenal bypass: indications and outcomes following 41 reconstructions.
- Results of the national pilot screening program for Venous disease by the American Venous Forum.
- Acute limb ischemia associated with type B Aortic dissection: clinical relevance and therapy.
- Targeted deletion of CCR2 impairs Deep vein thombosis resolution in a mouse model.
- Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases Vein wall injury in a rat stenosis model of venous thrombosis.
- Sonographic elasticity imaging of Acute and chronic deep venous thrombosis in humans.
- American Venous Forum: The future is now!
- Experimental pulmonary Embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin.
- A negative carotid plaque area test is superior to other noninvasive Atherosclerosis studies for reducing the likelihood of having underlying significant coronary arte...
- A role for interleukin-10 in the assessment of Venous thromboembolism risk in injured patients.
- Outcome of surgical and endoluminal intervention for infrainguinal bypass anastomotic strictures.
- Severe chronic Venous insufficiency: magnitude of the problem and consequences.
- The role of inflammation in early and late venous Thrombosis: Are there clinical implications?
- Decreased venous Thrombosis with an oral inhibitor of P selectin.
- L-selectin-mediated neutrophil recruitment in experimental rodent Aneurysm formation.
- Vein wall remodeling after Deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
- Osteomyelitis of the foot and toe in adults is a surgical Disease: conservative management worsens lower extremity salvage.
- Gender differences in Deep venous thrombosis in a rat model: a preliminary study.
- The treatment of Deep venous thrombosis, including the newer agents.
- Macrovascular Thrombosis is driven by tissue factor derived primarily from the blood vessel wall.
- Inflammation-dependent Thrombosis.
- Deep vein thrombosis resolution is not accelerated with increased neovascularization.
- Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model.
- Neutropenia impairs venous Thrombosis resolution in the rat.
- P-selectin and leukocyte microparticles are associated with Venous thrombogenesis.
- P-selectin inhibition decreases post-thrombotic Vein wall fibrosis in a rat model.
- Cellular IL-10 is more effective than viral IL-10 in decreasing venous Thrombosis.
- Clinical application of sonographic elasticity imaging for aging of Deep venous thrombosis: preliminary findings.
- P-selectin inhibition enhances thrombus resolution and decreases Vein wall fibrosis in a rat model.
- Endovascular treatment of Abdominal aortic aneurysm is associated with a low incidence of deep venous thrombosis.
- Compression stockings and Venous function.
- Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary Embolism.
- Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infrainguinal Arterial reconstruction.
Schools
University of Toledo College of Medicine
University Mich Med Center
Procedures Preformed
- Ablation
- ArterioVenous Shunt Creation
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Non-Coronary Angioplasty, Atherectomy, and Stenting
- View All
Conditions Treated
- Abdominal Aortic Aneurysm (AAA)
- Acute Deep Vein Thrombosis (DVT)
- Acute Venous Embolism Thrombosis
- Aortic Aneurysm
- View All
Doctors Specialties
- Vascular Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Servier Traveling Research Award
- Coeur D'OR Award for Excellence
- Coeur D’OR Award for Excellence
- Distinguished Alumnus Award
- Venous Research Award of the Venous Disease Coalition
- CMS Meaningful Use Stage 1 Certification
- ATVB Distinguished Invited Lecture
- Best Poster
- 1st Place Oral Presentation
- Invited speaker, AOA Induction Ceremony
- James K. Larson Award for Outstanding Career Achievement
- Emerick Szilagyi Award
- Servier Traveling Fellowship
- Elected
- Honorary Membership
- Participation in Surgeon General's Conference on VTE
- Participation in ASH/NIH Conference on VTE and Aging
- Distinguished Reviewer
- America's Top Doctors (America's Top Doctors by Specialty)
- America’s Top Doctors (America’s Top Doctors by Specialty)
- One of America's Best Doctors
- One of America’s Best Doctors
- President
- Order of Excellence
- President-Elect
- Distinguished Fellow
- Detroit's "Top Docs"
- Award for Excellence in Vascular Surgical Research
- William J von Liebig Foundation Award for Excellence in Vascular Surgical Research
- Selection into Strathmore’s Who’s Who
- Selection into Strathmore's Who's Who
- Award for best poster
- Frederick A. Coller Surgical Society Conrad Jobst Award
- Beiersdorf-Jobst Research Award
- Jody C. Underleider Award for Animal Welfare
- 2000 Beiersdorf-Jobst Research Award
- James W. Crudup Award
- 1st Place, Venous Research Award
- Lindenauer Vascular Research and Education Award
- Emerick Szilagyi Michigan Vascular Prize
- Charles C. Guthrie Award for Original Research in Vascular Disease
- Charles C. Guthrie Award
- Finalist, The Jobst Research Fellowship
- Finalist
- Induction into St. John's High School Hall of Fame
- 3rd Place, Venous Research Award
- Bronze Beeper Award for Outstanding Teaching
- Conrad Jobst Award
- Conrad Jobst Award for Research in Vascular Surgery
- Phi Kappa Phi Graduate Scholarship
- Governor's Award
- Top State Science Student
- National Winner
- Fellow (FACS)
Education
-
University of Michigan Hospitals and Health Centers -
University of Toledo College of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1902907819 | |
| NPPES Provider LastName | WAKEFIELD | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 481095329 | |
| NPPES Provider State | MI | |
| Specialty Description | Vascular Surgery | |
| Total Claim Count | 82.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 20.73 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902907819 |
| Last Name Of The Provider | WAKEFIELD |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Jonathan L. Eliason, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John E. Rectenwald, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dawn M. Coleman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guillermo A. Escobar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jordan P. Knepper, MD |
|
|
Dr. Frank C. Vandy, MD
This Doctor is OpenDoctor Recommended.
|